Evaluation of the pharmacokinetic (PK) profile of vismodegib (VISMO) in patients (pts) with multiple basal cell carcinomas (BCCs) across two intermittent treatment regimens in the MIKIE study
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2016-10, Vol.27, p.vi395-vi395 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | vi395 |
|---|---|
| container_issue | |
| container_start_page | vi395 |
| container_title | Annals of oncology |
| container_volume | 27 |
| creator | Schadendorf, D. Hauschild, A. Fosko, S. Zloty, D. Labeille, B. Grob, J.J. Puig, S. Makrutzki, M. Templeton, I. Rogers, G. Dreno, B. Kunstfeld, R. |
| description | |
| doi_str_mv | 10.1093/annonc/mdw379.46 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdw379_46</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419447753</els_id><sourcerecordid>S0923753419447753</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2746-df02588aa0d17f581392a4f95f33dea7d8787872bd95b36fa7b8e1a5274616913</originalsourceid><addsrcrecordid>eNp1kUlP6zAUhS0EEmXYs_SyXQTsOJPZvVcVqACBxLCNbjxQQxJHttuKX8dfw6FskSX7Ls537pEPQmeUnFPC2QX0ve3FRSe3rOTnWbGHJjQveFKRjO6jCeEpS8qcZYfoyPt3QkjBUz5BX4sNtGsIxvbYahxWCg8rcB0I-2F6FYzA08fbGR6c1aZVo2ZjfGelejMNnr4un-4fZtj0eIgeqg8eT4fgZ3hrwgp36zaYIVINeGixUG28wAnT2w6i8v98HqUgnPUeh62NPkG5zoQQnXBwCkI3Ti4ui4Mf94wJ75e3ywX2YS0_T9CBhtar09_3GL1cLZ7nN8ndw_Vy_u8uEWmZFYnUJM2rCoBIWuq8ooynkGmea8akglJW5XjSRvK8YYWGsqkUhXyEacEpO0Zk5_sT1ildD8504D5rSuqxgHpXQL0roM6KiFzuEBVzbYxytRfxi4SSxikRamnN3_A3b6qTDw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Evaluation of the pharmacokinetic (PK) profile of vismodegib (VISMO) in patients (pts) with multiple basal cell carcinomas (BCCs) across two intermittent treatment regimens in the MIKIE study</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Schadendorf, D. ; Hauschild, A. ; Fosko, S. ; Zloty, D. ; Labeille, B. ; Grob, J.J. ; Puig, S. ; Makrutzki, M. ; Templeton, I. ; Rogers, G. ; Dreno, B. ; Kunstfeld, R.</creator><creatorcontrib>Schadendorf, D. ; Hauschild, A. ; Fosko, S. ; Zloty, D. ; Labeille, B. ; Grob, J.J. ; Puig, S. ; Makrutzki, M. ; Templeton, I. ; Rogers, G. ; Dreno, B. ; Kunstfeld, R.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdw379.46</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2016-10, Vol.27, p.vi395-vi395</ispartof><rights>2016 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Schadendorf, D.</creatorcontrib><creatorcontrib>Hauschild, A.</creatorcontrib><creatorcontrib>Fosko, S.</creatorcontrib><creatorcontrib>Zloty, D.</creatorcontrib><creatorcontrib>Labeille, B.</creatorcontrib><creatorcontrib>Grob, J.J.</creatorcontrib><creatorcontrib>Puig, S.</creatorcontrib><creatorcontrib>Makrutzki, M.</creatorcontrib><creatorcontrib>Templeton, I.</creatorcontrib><creatorcontrib>Rogers, G.</creatorcontrib><creatorcontrib>Dreno, B.</creatorcontrib><creatorcontrib>Kunstfeld, R.</creatorcontrib><title>Evaluation of the pharmacokinetic (PK) profile of vismodegib (VISMO) in patients (pts) with multiple basal cell carcinomas (BCCs) across two intermittent treatment regimens in the MIKIE study</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kUlP6zAUhS0EEmXYs_SyXQTsOJPZvVcVqACBxLCNbjxQQxJHttuKX8dfw6FskSX7Ls537pEPQmeUnFPC2QX0ve3FRSe3rOTnWbGHJjQveFKRjO6jCeEpS8qcZYfoyPt3QkjBUz5BX4sNtGsIxvbYahxWCg8rcB0I-2F6FYzA08fbGR6c1aZVo2ZjfGelejMNnr4un-4fZtj0eIgeqg8eT4fgZ3hrwgp36zaYIVINeGixUG28wAnT2w6i8v98HqUgnPUeh62NPkG5zoQQnXBwCkI3Ti4ui4Mf94wJ75e3ywX2YS0_T9CBhtar09_3GL1cLZ7nN8ndw_Vy_u8uEWmZFYnUJM2rCoBIWuq8ooynkGmea8akglJW5XjSRvK8YYWGsqkUhXyEacEpO0Zk5_sT1ildD8504D5rSuqxgHpXQL0roM6KiFzuEBVzbYxytRfxi4SSxikRamnN3_A3b6qTDw</recordid><startdate>20161001</startdate><enddate>20161001</enddate><creator>Schadendorf, D.</creator><creator>Hauschild, A.</creator><creator>Fosko, S.</creator><creator>Zloty, D.</creator><creator>Labeille, B.</creator><creator>Grob, J.J.</creator><creator>Puig, S.</creator><creator>Makrutzki, M.</creator><creator>Templeton, I.</creator><creator>Rogers, G.</creator><creator>Dreno, B.</creator><creator>Kunstfeld, R.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20161001</creationdate><title>Evaluation of the pharmacokinetic (PK) profile of vismodegib (VISMO) in patients (pts) with multiple basal cell carcinomas (BCCs) across two intermittent treatment regimens in the MIKIE study</title><author>Schadendorf, D. ; Hauschild, A. ; Fosko, S. ; Zloty, D. ; Labeille, B. ; Grob, J.J. ; Puig, S. ; Makrutzki, M. ; Templeton, I. ; Rogers, G. ; Dreno, B. ; Kunstfeld, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2746-df02588aa0d17f581392a4f95f33dea7d8787872bd95b36fa7b8e1a5274616913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schadendorf, D.</creatorcontrib><creatorcontrib>Hauschild, A.</creatorcontrib><creatorcontrib>Fosko, S.</creatorcontrib><creatorcontrib>Zloty, D.</creatorcontrib><creatorcontrib>Labeille, B.</creatorcontrib><creatorcontrib>Grob, J.J.</creatorcontrib><creatorcontrib>Puig, S.</creatorcontrib><creatorcontrib>Makrutzki, M.</creatorcontrib><creatorcontrib>Templeton, I.</creatorcontrib><creatorcontrib>Rogers, G.</creatorcontrib><creatorcontrib>Dreno, B.</creatorcontrib><creatorcontrib>Kunstfeld, R.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schadendorf, D.</au><au>Hauschild, A.</au><au>Fosko, S.</au><au>Zloty, D.</au><au>Labeille, B.</au><au>Grob, J.J.</au><au>Puig, S.</au><au>Makrutzki, M.</au><au>Templeton, I.</au><au>Rogers, G.</au><au>Dreno, B.</au><au>Kunstfeld, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of the pharmacokinetic (PK) profile of vismodegib (VISMO) in patients (pts) with multiple basal cell carcinomas (BCCs) across two intermittent treatment regimens in the MIKIE study</atitle><jtitle>Annals of oncology</jtitle><date>2016-10-01</date><risdate>2016</risdate><volume>27</volume><spage>vi395</spage><epage>vi395</epage><pages>vi395-vi395</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdw379.46</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2016-10, Vol.27, p.vi395-vi395 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdw379_46 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | Evaluation of the pharmacokinetic (PK) profile of vismodegib (VISMO) in patients (pts) with multiple basal cell carcinomas (BCCs) across two intermittent treatment regimens in the MIKIE study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T23%3A54%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20the%20pharmacokinetic%20(PK)%20profile%20of%20vismodegib%20(VISMO)%20in%20patients%20(pts)%20with%20multiple%20basal%20cell%20carcinomas%20(BCCs)%20across%20two%20intermittent%20treatment%20regimens%20in%20the%20MIKIE%20study&rft.jtitle=Annals%20of%20oncology&rft.au=Schadendorf,%20D.&rft.date=2016-10-01&rft.volume=27&rft.spage=vi395&rft.epage=vi395&rft.pages=vi395-vi395&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdw379.46&rft_dat=%3Celsevier_cross%3ES0923753419447753%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753419447753&rfr_iscdi=true |